Cuprina Holdings (Cayman) Ltd (CUPR) Stock Forecast Nov. 6, 2026
Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Cuprina Holdings (Cayman) Ltd (CUPR) stock forecast summary
Our AI scores Cuprina Holdings (Cayman) Ltd every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Cuprina Holdings (Cayman) Ltd is a small-cap company with a market capitalization of $12M. It ranks number 20 by market capitalization among the 26 Orthopedic, Prosthetic & Surgical Appliances & Supplies issuers in our coverage with a current forecast.
For CUPR, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 44.0%, measured on 214 forecast dates between 2025-05-16 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 13.0%, measured on 257 forecast dates between 2025-05-16 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, CUPR included.
CUPR price chart and AI forecast
How CUPR ranks among 5150 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Cuprina Holdings (Cayman) Ltd (CUPR) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Orthopedic, Prosthetic & Surgical Appliances & Supplies peers listed below that report each metric. Statement values were filed in SGD and are shown converted to USD (flows at the trailing twelve-month average rate, balances at the balance-sheet date rate).
Financial statement data is not available for this company: its filings are not in a form the pipeline converts, so only market data is shown.
Valuation & Market
| Metric | CUPR | Rank |
|---|---|---|
| Market Cap | $12M | 20/26 |
Dividend & Shareholder Information
| Metric | CUPR | Rank |
|---|---|---|
| Shares Outstanding | 7M | – |
CUPR quarterly financials and insider trading
Cuprina Holdings (Cayman) Ltd (CUPR) industry peers
Companies classified under the same SEC industry code as Cuprina Holdings (Cayman) Ltd (Orthopedic, Prosthetic & Surgical Appliances & Supplies): 26 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| CUPR Cuprina Holdings (Cayman) Ltd | $12M | |
| ISRG Intuitive Surgical Inc | $156.96B | |
| STE Steris Plc | $24.60B | |
| ZBH Zimmer Biomet Holdings, Inc. | $20.38B | |
| SNN Smith & Nephew Plc | $13.67B | |
| ALGN Align Technology Inc | $11.79B | |
| MSA Msa Safety Inc | $6.56B | |
| ESTA Establishment Labs Holdings Inc. | $1.92B | |
| ENOV Enovis Corp | $1.57B | |
| CDRE Cadre Holdings, Inc. | $1.40B | |
| AVR Anteris Technologies Global Corp. | $555M | |
| SMTI Sanara Medtech Inc. | $290M | |
| INGN Inogen Inc | $160M | |
| LAKE Lakeland Industries Inc | $89M | |
| NTRB Nutriband Inc. | $68M | |
| APT Alpha Pro Tech Ltd | $56M | |
| COCH Envoy Medical, Inc. | $55M | |
| MYO Myomo, Inc. | $48M | |
| MLSS Milestone Scientific Inc. | $27M | |
| LFWD Lifeward Ltd. | $16M | |
| UEEC United Health Products, Inc. | $10M | |
| RGNT Regentis Biomaterials Ltd. | $8M | |
| CLGN Collplant Biotechnologies Ltd | $7M | |
| BBLG Bone Biologics Corp | $1M | |
| FEED Envue Medical, Inc. | $240K | |
| RBOT Vicarious Surgical Inc. | $10K |
Where CUPR sits on the market map
Cuprina Holdings (Cayman) Ltd (CUPR) stock news
Loading...
Cuprina Holdings (Cayman) Ltd (CUPR) stock forecast FAQ
What is the Cuprina Holdings (Cayman) Ltd (CUPR) stock forecast?
Our AI scores Cuprina Holdings (Cayman) Ltd every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
How accurate are Cuprina Holdings (Cayman) Ltd stock predictions?
For CUPR, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 44.0%, measured on 214 forecast dates between 2025-05-16 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 13.0%, measured on 257 forecast dates between 2025-05-16 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Cuprina Holdings (Cayman) Ltd forecasts updated?
Cuprina Holdings (Cayman) Ltd forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
Which companies are Cuprina Holdings (Cayman) Ltd's industry peers?
26 issuers in our coverage, CUPR included, share the SEC industry code Orthopedic, Prosthetic & Surgical Appliances & Supplies. The largest are: Intuitive Surgical Inc (ISRG), Steris Plc (STE), Zimmer Biomet Holdings, Inc. (ZBH), Smith & Nephew Plc (SNN), Align Technology Inc (ALGN), Msa Safety Inc (MSA).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.